Fonar (NASDAQ:FONR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Fonar (NASDAQ:FONR) to a hold rating in a research report report published on Friday.

Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Fonar in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Fonar Stock Performance

Shares of NASDAQ FONR opened at $14.04 on Friday. The company has a market cap of $87.07 million, a P/E ratio of 11.41 and a beta of 0.90. Fonar has a 52-week low of $12.00 and a 52-week high of $17.62. The firm’s fifty day moving average is $15.12 and its two-hundred day moving average is $15.13.

Fonar (NASDAQ:FONR) last released its quarterly earnings data on Monday, November 10th. The medical equipment provider reported $0.34 EPS for the quarter. The business had revenue of $26.04 million during the quarter. Fonar had a net margin of 7.99% and a return on equity of 5.22%.

Institutional Trading of Fonar

Several hedge funds have recently made changes to their positions in FONR. Empowered Funds LLC lifted its holdings in shares of Fonar by 7.7% in the 1st quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider’s stock valued at $296,000 after acquiring an additional 1,504 shares during the last quarter. Ritholtz Wealth Management purchased a new stake in Fonar during the second quarter valued at approximately $157,000. Bridgeway Capital Management LLC lifted its stake in shares of Fonar by 2.3% in the 2nd quarter. Bridgeway Capital Management LLC now owns 83,382 shares of the medical equipment provider’s stock valued at $1,247,000 after purchasing an additional 1,843 shares during the last quarter. Lakewood Asset Management LLC lifted its stake in shares of Fonar by 51.2% in the 3rd quarter. Lakewood Asset Management LLC now owns 16,564 shares of the medical equipment provider’s stock valued at $249,000 after purchasing an additional 5,607 shares during the last quarter. Finally, Inspire Advisors LLC purchased a new position in shares of Fonar in the 3rd quarter worth approximately $216,000. 50.64% of the stock is currently owned by hedge funds and other institutional investors.

Fonar Company Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.